The Territory Tourism Voucher is open to all Territorians aged over 18. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Their group supports the NTFB locally via donations of time, food, funds and advocacy. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$87.6 Million by the year 2027. The NT Government has announced more than 26,000 vouchers worth $200 each for Territorians to spend on tourism in the NT. EXECUTIVE SUMMARY1. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well, as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold. EXECUTIVE SUMMARY1. We go live at 8pm tonight! We are humbled and appreciative.” “The reason HungerMitao supports local food banks for hunger relief is for the efficiency, reach, consistency, reliability and urgency with which they are able to act,” said Raj Asava, Co-founder HungerMitao. VANCOUVER, British Columbia, March 12, 2021 (GLOBE NEWSWIRE) -- Health Logic Interactive Inc. (formerly FanLogic Interactive Inc.) (the "Corporation") announces that, given the recent announcement that the Alberta Securities Commission has revoked its previously issued cease trade order in respect of the Corporation’s securities, and the completion the TSX Venture Exchange review, the TSX Venture Exchange subsequently lifted its trading suspension on the Corporation’s common shares which will be reinstated for trading effective March 15, 2021. Now’s your chance to support the Territory and to help get you started, we’re giving you a Territory Tourism Voucher. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Expanders Industry" - https://www.reportlinker.com/p06033136/?utm_source=GNW In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Conversion of Subsidiary Promissory Notes The Corporation also announces that, subject to the approval of the TSX Venture Exchange, it will seek to obtain agreement with the arm’s length holders of an aggregate of $140,000 principal amount of unsecured promissory notes (the "Subsidiary Notes") issued by a wholly-owned subsidiary of the Corporation to the assumption of the obligations under those notes by the Corporation and the issuance of 2,800,000 units ("Subsidiary Note Units") of the Corporation, at a deemed price of $0.05 per Subsidiary Note Unit, in full and final settlement of all principal and interest outstanding under such notes. Brazilian education group Grupo SEB plans to spin off its premium K-12 schools business and list it on Nasdaq, controlling shareholder and chief executive Chaim Zaher told Reuters. We are thankful to NTFB for providing sustained support to our neighbors facing hunger.” To learn more about the team behind HungerMitao visit ntfb.org/hungermitao # # # About North Texas Food Bank The North Texas Food Bank (NTFB) is a top-ranked nonprofit hunger-relief organization operating a state-of-the-art volunteer and distribution center in Plano, the Perot Family Campus. The TSXV has conditionally approved the listing of: (i) the Common Shares and the Warrants issued pursuant to the Offering, (ii) the Common Shares issuable upon exercise of the Warrants, and (iii) the Common Shares and Warrants forming part of the compensation units issued to the Underwriters in connection with the Offering. We are going to have a voucher system that backs in our tourism operators, that backs in Territorians,” Gunner said. ... Tourism NT will make a final decision as to whether all criteria has been met, and that decision is final. Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 6. Voucher holders can book online, over the phone or in person through their local visitor information centres in Darwin, Katherine, Tennant Creek and Alice Springs. To help get you started grab your Territory Tourism Voucher, for every dollar you spend it will be matched up to $200, to go towards your next Territory tourism experience. That is what the voucher system is. Voucher bookings and travel must be completed by 31 October 2020. Territorians can take up to $200 off a tourism booking with a Territory Tourism Voucher 10 June 2020 The Territory Government has announced a tourism voucher scheme to encourage Territorians to explore the Territory and support local tourism businesses until borders can safely re-open to interstate visitors. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-motion-acquisition-corp. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Congressman Richie Torres (D-NY) joined Yahoo Finance Live to discuss the impact of the $1.9 trillion stimulus plan. The vouchers will give Queenslanders a 50% discount on eligible tourism attractions, to the value of $200. Vouchers are valid for 30 days only. Valued up to $200, the vouchers are redeemable on a $1 for $1 basis across the Northern Territory, and can be used on multiple tourism experiences. The Northern Territory and South Australia have zero active cases, while Western Australia has only 28. But until then, he called on residents to back local businesses. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Accessories & Consumables segment is readjusted to a revised 5.1% CAGR for the next 7-year period. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. Bitcoin fell after news of the Binance investigation was reported, and was down 2% to $56,420.45 as of 10:42 am New York Time. There is no guarantee that such conditions precedent will be satisfied or that any of the transactions will be completed as described herein or at all. Each Private Placement Warrant shall entitle the holder thereof to acquire one Common Share in the capital of the Corporation (a “Private Placement Warrant Share”) at an exercise price of $0.10 per Private Placement Warrant Share for a period of six months from closing, subject to adjustment in certain events. The Corporation intends to acquire and commercialize consumer focused healthcare technologies that address areas of unmet needs, such as chronic disease management through point-of-care diagnostic medical devices that are connected to patient’s smartphones and virtual continued care platforms. The tourism scheme, announced by the State Government on Sunday, has been launched in a bid to boost tourism in the struggling region which has been hard hit by the pandemic and the loss of international travellers. China will remain among the fastest growing in this cluster of regional markets. Thousands of Territorians have been left frustrate d after an overwhelming response to the NT Government’s $200 Tourism Vouchers crashed the website.. MARKET ANALYSISUNITED STATES Market Facts & Figures Market Analytics Table 34: USA Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: USA Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: USA 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 37: USA Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 CANADA Table 43: Canada Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Canada Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: Canada 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 46: Canada Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 JAPAN Table 52: Japan Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Japan Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Japan 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 55: Japan Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Japan Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Japan 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 58: Japan Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Japan Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Japan 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 CHINA Table 61: China Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: China Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: China 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 64: China Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: China Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: China 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 67: China Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: China Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: China 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures Market Analytics Table 70: Europe Current & Future Analysis for Tissue Sectioning by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 71: Europe Historic Review for Tissue Sectioning by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Europe 15-Year Perspective for Tissue Sectioning by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 73: Europe Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: Europe Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: Europe 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 76: Europe Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: Europe Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Europe 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 79: Europe Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Europe Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Europe 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 FRANCE Table 82: France Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: France Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: France 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 85: France Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: France Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: France 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 88: France Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: France Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: France 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 GERMANY Table 91: Germany Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Germany Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Germany 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 94: Germany Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Germany Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Germany 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 97: Germany Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: Germany Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: Germany 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 ITALY Table 100: Italy Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: Italy Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: Italy 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 103: Italy Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: Italy Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: Italy 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 106: Italy Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: Italy Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: Italy 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 109: UK Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: UK Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: UK 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 112: UK Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: UK Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: UK 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 115: UK Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: UK Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: UK 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 REST OF EUROPE Table 118: Rest of Europe Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: Rest of Europe Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: Rest of Europe 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 121: Rest of Europe Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: Rest of Europe Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: Rest of Europe 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 124: Rest of Europe Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: Rest of Europe Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: Rest of Europe 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 127: Asia-Pacific Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 128: Asia-Pacific Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 129: Asia-Pacific 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 130: Asia-Pacific Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 131: Asia-Pacific Historic Review for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 132: Asia-Pacific 15-Year Perspective for Tissue Sectioning by End-Use - Percentage Breakdown of Value Sales for Research Centers, Hospitals, Diagnostic Laboratories and Clinics for the Years 2012, 2020 & 2027 Table 133: Asia-Pacific Current & Future Analysis for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 134: Asia-Pacific Historic Review for Tissue Sectioning by Technology - Automatic, Semi-Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 135: Asia-Pacific 15-Year Perspective for Tissue Sectioning by Technology - Percentage Breakdown of Value Sales for Automatic, Semi-Automatic and Manual for the Years 2012, 2020 & 2027 REST OF WORLD Table 136: Rest of World Current & Future Analysis for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 137: Rest of World Historic Review for Tissue Sectioning by Component - Instruments, Accessories & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 138: Rest of World 15-Year Perspective for Tissue Sectioning by Component - Percentage Breakdown of Value Sales for Instruments, Accessories & Consumables and Services for the Years 2012, 2020 & 2027 Table 139: Rest of World Current & Future Analysis for Tissue Sectioning by End-Use - Research Centers, Hospitals, Diagnostic Laboratories and Clinics - Independent Analysis of Annual Sales Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033137/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution.